英国胃肠病学会成人炎症性肠病管理共识指南
Ulcerative colitis and Crohn's disease are the principal forms of inflammatory bowel disease. Both represent chronic inflammation of the gastrointestinal tract, which displays heterogeneity in inflammatory and symptomatic burden between patients and within individuals over time.…
要点
- 指南覆盖成人炎症性肠病的药物、非药物及手术干预及服务提供。
- 推荐涉及免疫抑制治疗的指征、启动与监测及营养干预。
核心结论
- 指南为成人溃疡性结肠炎和克罗恩病管理提供168条循证与专家意见推荐。
研究设计与样本
- 由英国多学科利益相关方(包括医生、外科医生、专科护士、儿科医生、营养师、放射科医生、全科医生和患者)制定的共识指南。
- 基于88 247篇出版物的系统评价和涉及81名多学科临床医生及患者的Delphi共识流程。
主要发现
- 制定了168条关于药物、非药物和手术干预及最佳服务提供的推荐。
- 提供了免疫抑制治疗的指征、启动和监测、营养干预、术前术中术后管理及多学科团队结构和功能的最新指导。
关键数值与推荐
- 推荐条款涵盖免疫抑制治疗的指征、启动与监测。
- 推荐条款涵盖营养干预。
- 推荐条款涵盖术前、术中和术后管理。
- 推荐条款涵盖多学科团队的结构与功能及初级与二级医疗的整合。
临床怎么用
- 临床医生应与患者合作,基于证据个体化应用指南推荐进行成人炎症性肠病管理。
- 应用指南指导免疫抑制治疗的启动与监测、营养干预及围手术期管理。
- 参考指南优化多学科团队服务提供及初级与二级医疗的整合。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Ulcerative colitis and Crohn's disease are the principal forms of inflammatory bowel disease. Both represent chronic inflammation of the gastrointestinal tract, which displays heterogeneity in inflammatory and symptomatic burden between patients and within individuals over time. Optimal management relies on understanding and tailoring evidence-based interventions by clinicians in partnership with patients. This guideline for management of inflammatory bowel disease in adults over 16 years of age was developed by Stakeholders representing UK physicians (British Society of Gastroenterology), surgeons (Association of Coloproctology of Great Britain and Ireland), specialist nurses (Royal College of Nursing), paediatricians (British Society of Paediatric Gastroenterology, Hepatology and Nutrition), dietitians (British Dietetic Association), radiologists (British Society of Gastrointestinal and Abdominal Radiology), general practitioners (Primary Care Society for Gastroenterology) and patients (Crohn's and Colitis UK). A systematic review of 88 247 publications and a Delphi consensus process involving 81 multidisciplinary clinicians and patients was undertaken to develop 168 evidence- and expert opinion-based recommendations for pharmacological, non-pharmacological and surgical interventions, as well as optimal service delivery in the management of both ulcerative colitis and Crohn's disease. Comprehensive up-to-date guidance is provided regarding indications for, initiation and monitoring of immunosuppressive therapies, nutrition interventions, pre-, peri- and postoperative management, as well as structure and function of the multidisciplinary team and integration between primary and secondary care. Twenty research priorities to inform future clinical management are presented, alongside objective measurement of priority importance, determined by 2379 electronic survey responses from individuals living with ulcerative colitis and Crohn's disease, including patients, their families and friends.
引用
- Lamb CA, Kennedy NA, Raine T, et al. British Society of Gastroenterology consensus guidelines on the management of inflammatory bowel disease in adults. Gut. 2019. PMID: 31562236. doi:10.1136/gutjnl-2019-318484
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。